Filing Details
- Accession Number:
- 0001127602-12-024878
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-20 16:53:02
- Reporting Period:
- 2012-08-16
- Filing Date:
- 2012-08-20
- Accepted Time:
- 2012-08-20 16:53:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238330 | Ann Jo Golden | C/O Conmed Corp 525 French Road Utica NY 13502-5994 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-08-16 | 500 | $16.46 | 10,117 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-08-16 | 304 | $27.09 | 9,813 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2012-08-16 | 1,100 | $27.05 | 8,713 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-08-20 | 100 | $27.18 | 8,613 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-08-20 | 100 | $27.09 | 8,513 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2012-08-16 | 500 | $0.00 | 500 | $16.46 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,000 | 2019-06-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.08. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed or a ConMed security holder.
- The stock appreciation rights ("SARs") were granted under the Company's 2007 Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 20% per year over a five year period, with any unvested SARs to vest upon the Director's termination of service provided the Director has completed one full year of service since the date of the award in which case the SARS shall be exercisable at any time prior to the expiration date of the SAR or within one year after the date of such termination, whichever period is shorter.
Billionaire Hedge Funds
